The developed recombinant bacteriophage displayed the extracellular domain of VEGFR2, thus providing the competitive inhibition and capture of VEGF, a key factor in tumor angiogenesis overexpressed by cancer cells. The gene discussed is KDR; the disease is neoplasm.